These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 8595609)
1. Effect of catecholamine depletion on myocardial infarct size in dogs: role of catecholamines in ischemic preconditioning. Vander Heide RS; Schwartz LM; Jennings RB; Reimer KA Cardiovasc Res; 1995 Nov; 30(5):656-62. PubMed ID: 8595609 [TBL] [Abstract][Full Text] [Related]
2. Ischemic preconditioning fails to limit infarct size in reserpinized rabbit myocardium. Implication of norepinephrine release in the preconditioning effect. Toombs CF; Wiltse AL; Shebuski RJ Circulation; 1993 Nov; 88(5 Pt 1):2351-8. PubMed ID: 8222128 [TBL] [Abstract][Full Text] [Related]
3. Intracoronary administration of the alpha 1-receptor agonist, methoxamine, does not reproduce the infarct-limiting effect of ischemic preconditioning in dogs. Sebbag L; Katsuragawa M; Verbinski S; Jennings RB; Reimer KA Cardiovasc Res; 1996 Nov; 32(5):830-8. PubMed ID: 8944813 [TBL] [Abstract][Full Text] [Related]
4. Reduction in infarct size by ischemic preconditioning persists in a chronic rat model of myocardial ischemia-reperfusion injury. Lott FD; Guo P; Toombs CF Pharmacology; 1996 Feb; 52(2):113-8. PubMed ID: 8851632 [TBL] [Abstract][Full Text] [Related]
5. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs. Vander Heide RS; Reimer KA Cardiovasc Res; 1996 May; 31(5):711-8. PubMed ID: 8763400 [TBL] [Abstract][Full Text] [Related]
6. Premedication with the opioid analgesic butorphanol raises the threshold for ischemic preconditioning in dogs. Schwartz LM; Jennings RB; Reimer KA Basic Res Cardiol; 1997 Apr; 92(2):106-14. PubMed ID: 9166990 [TBL] [Abstract][Full Text] [Related]
7. Ischemic preconditioning elevates cardiac stress protein but does not limit infarct size 24 or 48 h later in rabbits. Tanaka M; Fujiwara H; Yamasaki K; Miyamae M; Yokota R; Hasegawa K; Fujiwara T; Sasayama S Am J Physiol; 1994 Oct; 267(4 Pt 2):H1476-82. PubMed ID: 7943394 [TBL] [Abstract][Full Text] [Related]
8. The possible role of adrenergic component in ischemic preconditioning. Sharma A; Singh M Methods Find Exp Clin Pharmacol; 1997 Sep; 19(7):493-9. PubMed ID: 9413833 [TBL] [Abstract][Full Text] [Related]
9. Myocardial protection is lost before contractile function recovers from ischemic preconditioning. Murry CE; Richard VJ; Jennings RB; Reimer KA Am J Physiol; 1991 Mar; 260(3 Pt 2):H796-804. PubMed ID: 2000974 [TBL] [Abstract][Full Text] [Related]
10. Cardioprotective effect of ischemic preconditioning is preserved in food-restricted senescent rats. Abete P; Testa G; Ferrara N; De Santis D; Capaccio P; Viati L; Calabrese C; Cacciatore F; Longobardi G; Condorelli M; Napoli C; Rengo F Am J Physiol Heart Circ Physiol; 2002 Jun; 282(6):H1978-87. PubMed ID: 12003801 [TBL] [Abstract][Full Text] [Related]
11. Preconditioning with supply-demand imbalance limits infarct size in dog heart. Iwamoto T; Bai XJ; Downey HF Cardiovasc Res; 1993 Nov; 27(11):2071-6. PubMed ID: 8287420 [TBL] [Abstract][Full Text] [Related]
12. Remote preconditioning by infrarenal aortic occlusion is operative via delta1-opioid receptors and free radicals in vivo in the rat heart. Weinbrenner C; Schulze F; Sárváry L; Strasser RH Cardiovasc Res; 2004 Feb; 61(3):591-9. PubMed ID: 14962489 [TBL] [Abstract][Full Text] [Related]
13. Endogenous myocardial norepinephrine is not essential for ischemic preconditioning in rabbit heart. Ardell JL; Yang XM; Barron BA; Downey JM; Cohen MV Am J Physiol; 1996 Mar; 270(3 Pt 2):H1078-84. PubMed ID: 8780206 [TBL] [Abstract][Full Text] [Related]
14. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction. Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911 [TBL] [Abstract][Full Text] [Related]
15. Cardiac protection by ischaemic preconditioning is not mediated by myocardial stunning. Matsuda M; Catena TG; Vander Heide RS; Jennings RB; Reimer KA Cardiovasc Res; 1993 Apr; 27(4):585-92. PubMed ID: 8324790 [TBL] [Abstract][Full Text] [Related]
16. The novel calcium antagonist Ro 40-5967 limits myocardial infarct size in the dog. Vander Heide RS; Schwartz LM; Reimer KA Cardiovasc Res; 1994 Oct; 28(10):1526-32. PubMed ID: 8001041 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK. Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474 [TBL] [Abstract][Full Text] [Related]
18. Reduction of regional contractile function by preconditioning ischemia does not play a permissive role in the infarct size-limitation by the preconditioning. Goto M; Miura T; Itoya M; Sakamoto J; Iimura O Basic Res Cardiol; 1993; 88(6):594-606. PubMed ID: 8147824 [TBL] [Abstract][Full Text] [Related]
19. Infarct-size limitation by preconditioning is enhanced by dipyridamole administered before but not after preconditioning: evidence for the role of interstitial adenosine level during preconditioning as a primary determinant of cardioprotection. Suzuki K; Miura T; Miki T; Tsuchida A; Shimamoto K J Cardiovasc Pharmacol; 1998 Jan; 31(1):1-9. PubMed ID: 9456270 [TBL] [Abstract][Full Text] [Related]
20. Duration and reinstatement of myocardial protection against infarction by ischemic preconditioning in open chest dogs. Schwartz LM; Sebbag L; Jennings RB; Reimer KA J Mol Cell Cardiol; 2001 Sep; 33(9):1561-70. PubMed ID: 11549337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]